Table 1.

Adverse events in 15 patients who were enrolled in our study.

Adverse event	1–2 Grade	3–5 Grade
Rash	4 (26.7%)	0
Hypothyroidism	1 (6.7%)	0
Arrhythmia	0	0
Pneumonitis	0	1 (6.7%)
Stomatitis	1 (6.7%)	0
Liver dysfunction	0	0
Gastroenteritis	0	0
Cerebral thrombosis	0	1 (6.7%)